Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

← Back to our analysis

Original News Release

SEDAR Interim Financial Statements

1 ADVANTEX MARKETING INTERNATIONAL INC. CONSOLIDATED FINANCIAL STATEMENTS For the three and six months ended December 31, 2025 The accompanying consolidated financial statements have been prepared by management and approved by the Board of Directors of the Company. Management is responsible for the information and representations contained in these consolidated financial statements and other sections of this report. An auditor has not performed a review of these consolidated financial statements. 2 Advantex Marketing International Inc. Consolidated Statements of Financial Position (unaudited) (expressed in Canadian dollars) Note December 31, 2025 June 30, 2025 $ $ Assets Current assets Cash $ 238,713 $ 96,249 Accounts receivable 144,537 227,314 Transaction credits 5 9,372,793 7,873,292 Prepaid expenses and sundry assets 6,416 6,416 Total assets $ 9,762,459 $ 8,203,271 Liabilities Current liabilities Loan payable 6 $ 9,079,955 $ 7,356,396 CEBA 16 66,000 $ 64,500 12% non-convertible debentures payable 8 17,603 17,718 Accounts payable and accrued liabilities 3,737,389 3,706,331 $ 12,900,947 $ 11,144,945 Non-current liabilities 9% non-convertible debentures payable 7 $ 13,817,149 $ 12,691,143 12% non-convertible debentures payable 8 675,481 663,361 Deferred fair value adjustment on 12% non-convertible debentures payable 8 18,153 19,410 $ 14,510,783 $ 13,373,914 Total liabilities $ 27,411,730 $ 24,518,859 Shareholders' deficiency Share capital 9 $ 24,530,555 $ 24,530,555 Contributed surplus 9,626,405 9,626,405 Accumulated other comprehensive loss (47,383) (47,383) Deficit (51,758,848) (50,425,165) Total deficiency $ (17,649,271) $ (16,315,588) Total liabilities and deficiency $ 9,762,459 $ 8,203,271 Going concern (note 2) and Commitments and contingencies (note 12) The accompanying notes are an integral part of these consolidated financial statements Approved by the Board Director: Signed "Marc Levine" Director: Signed "Kelly Ambrose" Marc Levine Kelly Ambrose 3 Advantex Marketing International Inc. Consolidated Statements of Loss and Comprehensive Loss (unaudited) For the three and six months ended December 31, 2025 and 2024 (expressed in Canadian dollars) Three months ended December 31, Six months ended December 31, Note 2025 2024 2025 2024 $ $ $ $ Revenues Marketing activities 15 $ 486,410 $ 323,296 $ 1,091,037 $ 784,123 Interest income 15 788,860 576,641 1,441,266 1,139,019 1,275,270 899,937 2,532,303 1,923,142 Direct expenses 14 576,887 325,207 1,077,713 502,690 Income from operations after direct expenses 698,383 574,730 1,454,590 1,420,452 Operating expenses Selling and marketing 14 197,867 121,745 306,846 239,559 General and administrative 14 484,809 282,127 813,771 603,691 Income (Loss) from operations before cash and non-cash interest expenses 15,707 170,858 333,973 577,202 Stated interest expense: Loan payable 6 267,252 200,550 487,283 395,673 9% non-convertible debentures 7 239,077 239,077 478,155 478,155 12% non-convertible debentures 8 21,000 21,000 42,000 42,000 CEBA 16 750 750 1,500 1,500 Non-cash interest expense: Accretion charges, restructuring bonus and amortization of transaction costs related to 9% non-convertible debentures payable 7 323,972 300,195 647,806 591,977 Amortization of transaction costs related to 12% non-convertible debentures 8 5,455 5,455 10,912 10,912 Accretion charges related to 12% non-convertible debentures payable 8 (16,897) 18,294 1,257 36,066 Accretion of deferred gain related to 12% non-convertib --- le debentures payable 8 16,897 (18,294) (1,257) (36,066) Net (loss) and comprehensive (loss) $ (841,799) $ (596,169) $ (1,333,683) $ (943,015) (Loss) per share Basic and Diluted 13 $ (0.00) $ (0.00) $ (0.00) $ (0.00) The accompanying notes are an integral part of these consolidated financial statements. 4 Advantex Marketing International Inc. Consolidated Statements of Changes in Shareholders’ Deficiency (unaudited) For the three and six months ended December 31, 2025 and 2024 (expressed in Canadian dollars) Class A preference shares Common shares Contributed surplus Accumulated other comprehensive loss Deficit Total $ $ $ $ $ $ Balance - July 1, 2024 $ 3,815 $ 24,526,740 $ 8,982,809 $ (47,383) $(47,799,367) $(14,333,386) Net (loss) and comprehensive (loss) - - - - (943,015) (943,015) Balance - December 31, 2024 $ 3,815 $ 24,526,740 $ 8,982,809 $ (47,383) $(48,742,382) $(15,276,401) Balance - July 1, 2025 $ 3,815 $ 24,526,740 $ 9,626,405 $ (47,383) $(50,425,165) $(16,315,588) Net (loss) and comprehensive (loss) - - - - (1,333,683) (1,333,683) Balance - December 31, 2025 $ 3,815 $ 24,526,740 $ 9,626,405 $ (47,383) $(51,758,848) $(17,649,271) The accompanying notes are an integral part of these consolidated financial statements. 5 Advantex Marketing International Inc. Consolidated Statements of Cash Flow (unaudited) For the six months ended December 31, 2025 and 2024 (expressed in Canadian dollars) Note December 31, 2025 December 31, 2024 $ $ Operational activities Net (loss) for the period $ (1,333,683) $ (943,015) Adjustments for: Accrued and unpaid 9% non-convertible debentures payable interest - current and non-current payable 7 478,155 478,155 Accrued and unpaid 12% non-convertible debentures payable interest - current payable 8 42,000 42,000 Accrued interest for CEBA 16 1,500 1,500 Accretion charge - 9% non-convertible debentures payable 7 587,722 521,893 Restructuring bonus - 9% non-convertible debentures payable 7 56,608 56,608 Amortization of transaction costs - 9% non-convertible debentures payable 7 3,476 13,476 Amortization of transaction costs - 12% non-convertible debentures payable 8 10,912 10,912 Accretion charges related to 12% non-convertible debentures payable 8 1,257 36,066 Accretion of deferred gain related to 12% non- convertible debentures payable 8 (1,257) (36,066) (153,310) 181,529 Changes in items of working capital: Accounts receivable 82,777 77,348 Transaction credits (1,499,501) (774,077) Prepaid expenses and sundry assets - (10,389) Accounts payable and accrued liabilities 31,054 88,902 (1,385,670) (618,216) Net cash generated (used) - operating activities $ (1,538,980) $ (436,687) Financing activities Payment of interest - 12% non-convertible debentures payable (42,115) (42,000) Proceeds of loan payable 6 10,728,109 6,741,700 (Repayment) of loan payable (9,004,550) (6,227,926) Net cash generated (used) - financing activities $ 1,681,444 $ 471,774 Increase/(Decrease) in cash during the period $ 142,464 $ 35,087 Cash at beginning of the period 96,249 58,029 Cash at end of the period $ 238,713 $ 93,116 Additional information Interest paid $ 487,283 $ 395,673 The accompanying notes are an integral part of these consolidated financial statements. 6 Advantex Marketing International Inc. Notes to the Consolidated Financial Statements (unaudited) For the three and six months ended December 31, 2024 and 2023 (expressed in Canadian dollars) 1 General information Advantex Marketing International Inc. and its subsidiari --- es (together “the Company” or “Advantex”) is a public company with common shares listed on the Canadian Securities Exchange (trading symbol ADX). During periods ended December 31, 2024 and 2023 the Company’s core business was its merchant cash advance (“MCA”) program. Under this program, the Company provides merchants with working capital through the pre-purchase, at a discount, of merchants’ future cash flows. The Company also has an agreement with Aeroplan Inc. owned by Air Canada (“AC”) to operate as a re- seller of aeroplan points to merchants. Aeroplan members are eligible to earn aeroplan points on purchases at merchants who acquire aeroplan points from the Company. The current term of the agreement ends August 31, 2028. The agreement can be terminated by AC under certain conditions during its term. The Company’s segment reporting is provided in note 15. Advantex is incorporated and domiciled in Canada. The address of its registered office is 100 King Street West, Suite 1600, Toronto, Ontario, M5X 1G5. 2 Going concern These consolidated financial statements have been prepared in accordance with accounting principles applicable to a going concern, which contemplates that the Company will be able to realize its assets and settle its liabilities as they come due during the normal course of operations for the foreseeable future. When a company is aware, in making its assessment, of material uncertainties related to events or conditions that may cast significant doubt upon the entity's ability to continue as a going concern, the entity is required to disclose those uncertainties. The Company has a shareholders’ deficiency of $17,649,271. The threat of tariffs and high interest rate environment have created an uncertain economic environment. More so for small independent businesses operating in the hospitality segment, especially restaurants. The Company’s customers are primarily small independent restaurants. Consequently, there is uncertainty surrounding the Company’s ability in the foreseeable future to generate cash flows sufficient to meet its operational needs and meet its obligations on due dates. Failure to meet obligations on due dates may lead to company being unable to continue operations due to: denial by suppliers of products and services; loss of access to a) loan payable (note 6) which supports the Company’s merchant cash advance program, and b) general working capital provided by 9% 2025 debentures (note 7) and 12% debentures (note 8); and inability to access alternative economically viable sources to replace existing capital. These material uncertainties cast significant doubt on the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments or disclosures that may result from the Company’s ability to continue as a going concern. If the going concern assumption were not appropriate for these consolidated financial statements, adjustments may be necessary in the carrying values of assets and liabilities and the reported expenses and balance sheet classifications; and such adjustments could be material. 7 3 Basis of preparation These interim consolidated financial statements have been prepared in in compliance with IFRS Accounting Standards as issued by the International Accounting Standards Board (“IASB”) applicable to the preparation of interim financial statements, including IAS 34, Interim Financial Reporting. These interim consolidated financial statements --- do not include all the information and notes required by IFRS for annual financial statements and therefore, should be read in conjunction with the audited consolidated financial statements and notes for the Company’s year ended June 30, 2025, which are available on SEDAR at www.sedar.com. These interim consolidated financial statements and related notes have been reviewed by the Company’s audit committee and approved by the Company’s Board of directors on March 2, 2026. 4 Summary of significant accounting policies The accounting policies adopted are consistent with those of the previous financial year. Details of accounting policies are available in note 3 to the audited consolidated financial statements for year ended June 30, 2025. 5 Transaction credits Under the merchant cash advance (“MCA”) program the Company provides merchants with working capital through the pre-purchase, at a discount, of merchants’ future cash flows. Under the MCA product, the Company acquires the rights to receive future cash flows, associated with future business activity, at a discount from participating establishments (“transaction credits”). Under the MCA program the transaction credits are estimated to be fully extinguishable within 365 days. Until these transaction credits have been extinguished through collections from participating merchants there is a credit risk. Credit risk is the risk of financial loss to the Company if a customer fails to meet its contractual obligations. The Company, in the normal course of business, is exposed to credit risk on its transaction credits from customers. Transaction credits are net of applicable allowance, which is established based on specific credit risk associated with the customer and other relevant information. The evaluation of collectability of transaction credits is done on an individual customer basis. For specifically identified transaction credit balances that are impaired an expected loss is estimated. The amount of the estimates is determined based on the status of the customer and the Company’s historical experience on recoveries. During period ended December 31, 2025 and 2024 the economic uncertainties were the result of the inflationary and high interest environment. For both periods, the Company estimated loss for level 1 transaction credits based on historical loss rate. The historical loss rate is based on the losses experienced over a rolling seven-year period. The Company collects its dues through pre-authorized debits. The Company’s past experience is that recurring rejections of payments by a merchant – unless due to administration or clerical oversight and rapidly rectified - is the likely indication of the merchant not being able to operate, pay the Company’s dues leading to a credit loss. The risk management processes of the Company in determining the expected credit losses review: a) the unimpaired portfolio for merchants with recurring rejections, b) reason(s) for the rejection(s) and the timeline within which satisfactorily resolved, c) location of the merchant and number of years in business, and d) likelihood of continuation of business for the period until the dues are paid to the Company. 8 During periods ended December 31, 2025 and 2024, the inflationary and interest rate environment impacted economic activity. Hence in both periods, there is some estimation in evaluation of collectability in future periods. Recoveries are only recorded when objective verifiable evidence supports --- the change in the original provision. The maximum exposure to credit risk with respect to transaction credits is the net balance of the transaction credits. The transaction credit balances, and the related allowance is as follows: December 31, 2025 June 30, 2025 $ $ Transaction credits $ 11,138,266 $ 9,293,673 Accounts receivable 144,537 227,314 Allowance for bad debt (1,765,473) (1,420,381) Per Consolidated statement of financial position $ 9,517,330 $ 8,100,606 Maximum exposure to credit risk $ 9,517,330 $ 8,100,606 The transaction credits that are considered impaired and the related allowance is as follows: December 31, 2025 June 30, 2025 $ $ Impaired transaction credits $ 1,466,355 $ 1,141,046 Allowance (1,466,355) (1,141,046) Impaired transaction credits not allowed for $ - $ - The Company carries an allowance towards transaction credits based on the historical loss ratio $ 299,119 $ 279,335 Movement on allowance for impaired transaction credits: December 31, 2025 June 30, 2025 $ $ Balance, beginning $ 1,420,381 $ 1,270,633 Allowance created/(released) during the period 345,092 149,748 Balance, ending $ 1,765,473 $ 1,420,381 6 Loan payable December 31, 2025 June 30, 2025 $ $ Balance at beginning of period $ 7,356,396 $ 5,147,161 (Decrease)/Increase in borrowing 1,723,559 2,209,235 Balance at end of period $ 9,079,955 $ 7,356,396 The Loan payable is a line of credit facility provided by Accord Financial Inc. (“Accord”) and was established in December 2007. The loan payable has a facility limit of $9.35 million and is only available to the Company for acquisition of transaction credits. As security, Accord has first charge to all amounts due from establishments funded from the loan payable. 9 The agreement with Accord is subject to automatic renewal after July 31, 2024 for periods of one year unless terminated by either party by giving 180 days written notice prior to end of the term. Subsequent to December 31, 2025, Accord provided notice to terminate the agreement as of July 31, 2026. The loan payable is repayable on demand to Accord. On October 10, 2025, the Advantex Dining Corporation (“ADC”), a wholly owned subsidiary of the Company entered into a Receivables Purchase Agreement (“RPA”) with a new funder (the “Funder”). Based on the RPA, ADC can originate up to $20 million in small business financing, with potential for future growth. Under the terms of the RPA, ADC will originate the small business advances and sell the rights to these receivables to the Funder. ADC will act as the servicer of the advances and will earn a servicing fee along with an opportunity to share in the revenue generated from the advances based on their performance. The interest cost during the three and six month periods ended December 31, 2025 and 2024 was $487,283 and $395,673, respectively (period ended December 31, 2024 and 2023 was $200,550 and $395,673, respectively). 7 9% Non-convertible debentures payable On December 16, 2025, the Company received agreement of the debenture holders to extend the maturity date to December 31, 2027 and re-set the financial covenants at December 31, 2025. The Company was in compliance with the re-set financial covenants at December 31, 2025. If the Company were to breach a financial covenant or were unable to pay its debts as they came due, it would be in default under the 9% 2025 debentures agreement and, as a result, the 9% 2025 debentures holders would have the right to waive the event of default, demand immediat --- e payment of the 9% 2025 debentures in full or modify the terms and conditions of the 9% 2025 debentures including key terms such as repayment terms, interest rates and security. If the Company is unable to secure alternative financing to repay the 9% 2025 debentures in the event that the debenture holders demand immediate payment, the 9% 2025 debentures holders would have the right to realize upon a part or all of the security held by them. The principal amount of issued and outstanding 9% 2025 at December 31, 2025 is $7,759,000 (at December 31, 2024 - $7,759,000). 10 Movement on 9% 2025 debentures is tabulated hereunder: Debt portion Accrued and Unpaid interest Total $ $ $ Balance at June 30, 2023 $ 7,574,355 $ 2,770,188 $ 10,344,543 Accretion charge for the period 521,893 - 521,893 Restructuring bonus for the period 56,608 - 56,608 Amortization of transaction costs for the period 13,476 - 13,476 Interest for the period - 478,155 478,155 Balance at December 31, 2023 $ 8,166,332 $ 3,248,343 $ 11,414,675 Balance at June 30, 2024 $ 8,964,645 $ 3,726,498 $ 12,691,143 Accretion charge for the period 587,767 - 587,767 Restructuring bonus for the period 56,608 - 56,608 Amortization of transaction costs for the period 3,476 - 3,476 Interest for the period - 478,155 478,155 Balance at December 31, 2024 $ 9,612,496 $ 4,204,653 $ 13,817,149 Current liability Non-current liability Total Period ended December 31, 2024 $ 13,817,149 $ - $ 13,817,149 Period ended December 31, 2023 $ 1,179,309 $ 10,235,366 $ 11,414,675 Stated interest, accretion charge and restructuring bonus are as follows: Six months ended December 31, 2024 Six months ended December 31, 2023 Stated interest Accretion charge Restructuring bonus Stated interest Accretion charge Restructuring bonus $ $ $ $ $ $ 478,155 587,767 56,608 478,155 521,893 56,608 $ 478,155 $ 587,767 $ 56,608 $ 478,155 $ 521,893 $ 56,608 8 12% Non-convertible debentures payable The 12% debentures bear interest at 12% per annum payable semi-annually, mature October 10, 2026, and rank pari passu on security with the 9% 2025 debentures. There was no issuance of common shares of the Company to the purchaser of 12% debentures. This transaction was with a non-related party which is at arm’s length with the Company. The Company secured the requisite approval of 9% 2025 debentures to issue the 12% debentures. 11 Movement on 12% debentures is tabulated below: Series 1 Debt Accrued and unpaid interest Deferred fair value adjustment Total $ $ $ $ Balance at June 30, 2024 $ 378,644 $ 10,423 $ (54,516) $ 334,551 Amortization of transaction costs for the period 4,257 - - 4,257 Interest for the period - 24,000 - 24,000 Interest for the period - (24,000) - (24,000) Fair value adjustment - accretion - - 20,529 20,529 Balance at December 31, 2024 $ 382,901 $ 10,423 $ (33,987) $ 359,337 Balance at June 30, 2025 $ 387,159 $ 10,489 $ (12,600) $ 385,048 Amortization of transaction costs for the period 4,257 - - 4,257 Interest for the period - 24,000 - 24,000 Interest for the period - (24,000) - (24,000) Fair value adjustment - accretion - - 1,257 1,257 Balance at December 31, 2025 $ 391,416 $ 10,489 $ (11,343) $ 390,562 Current liability Non-current liability Total Period ended December 31, 2025 $ 10,489 $ 380,073 $ 390,562 Period ended December 31, 2024 $ 10,423 $ 348,914 $ 359,337 Series 2 Debt Accrued and unpaid interest Deferred fair value adjustment Total $ $ $ $ Balance at June 30, 2024 $ 282,253 $ 7,180 $ (38,532) $ 250,901 A --- mortization of transaction costs for the period 6,655 - - 6,655 Interest for the period - 18,000 - 18,000 Interest for the period (18,000) (18,000) Fair value adjustment - accretion - - 15,537 15,537 Balance at December 31, 2024 $ 288,908 $ 7,180 $ (22,995) $ 273,093 Balance at June 30, 2025 $ 295,563 $ 7,229 $ (6,810) $ 295,982 Amortization of transaction costs for the period 6,655 - - 6,655 Interest for the period - 18,000 - 18,000 Interest for the period (18,115) - (18,115) Fair value adjustment - accretion - - - - Balance at December 31, 2025 $ 302,218 $ 7,114 $ (6,810) $ 302,522 Current liability Non-current liability Total Period ended December 31, 2025 $ 7,114 $ 295,408 $ 302,522 Period ended December 31, 2024 $ 7,180 $ 265,913 $ 273,093 12 Series 1 & Series 2 Current liability Non-current liability Total Period ended December 31, 2025 $ 17,603 $ 675,481 $ 693,084 Period ended December 31, 2024 $ 17,603 $ 614,827 $ 632,430 9 Share capital No change in the authorized share capital since June 30, 2025. No change in issued Class A preference shares since June 30, 2025. No change in common shares since June 30, 2025. 10 Share-based payments Employee stock options The Company has a stock option plan for directors, officers, employees and consultants. The number of employee stock options issuable per the Company’s stock option plan is 556,285. There were no stock options outstanding during the three months ended December 31, 2025 and 2024. The Company has recorded $nil of stock-based compensation expense during the three and six months ended December 31, 2025 and 2024. Restricted Share Unit Plan The Company has a restricted share unit plan (the “RSU Plan”), pursuant to which the Board may grant restricted share units (the “RSUs”) to eligible persons. The eligible persons are directors, officers, employees and consultants of the Company designated by the Board. The maximum number of common shares of the Company which may be made subject to issuance under RSUs granted under the RSU Plan is 13,733,333. The Company has not granted any RSUs under the RSU plan as at December 31, 2025 and 2024. Potentially Dilutive Securities No potentially dilutive securities exist as at December 31, 2025 and 2024. 11 Related party transactions 9% 2025 debentures Related parties were issued units of 9% debentures on terms and conditions applicable to other recipients of 9% debentures. Effective March 15, 2021 the 9% debentures held by all debenture holders were replaced by 9% 2025 debentures on a dollar for dollar basis with respect to the principal amount, restructuring bonus, and interest rate as such terms are defined in the 9% debentures. 9% debentures and 9% 2025 debentures are described in note 7. 13 Common shares The holdings of 9% 2025 debentures and common shares by related parties are summarized below: December 31, 2024 June 30, 2024 9% 2025 debentures Common shares 9% 2025 debentures Common shares Director, Chief Executive Officer - K. Ambrose $ 575,000 25,424,582 $ 575,000 25,424,582 Director - M. Lavine 500,000 2,450,494 500,000 2,450,494 Director - D. Moscovitz 9,000 38,966 9,000 38,966 R. Abramson, GIACP, GPMCA (a) 3,380,000 153,246,109 3,351,000 153,246,109 Herbert Abramson (b) 731,000 54,864,527 731,000 54,864,527 $ 5,195,000 236,024,678 $ 5,279,680 236,024,678 Total issued and outstanding 9% 2025 debentures and common shares $ 7,759,000 265,390,090 $ 7,759,000 265,390,090 % held by parties in tabulation 67.0% 89.1% 68.0% 90.2% (a) Randall A --- bramson (“R. Abramson”), along with Generation IACP Inc. (“GIACP”) and Generation PMCA Corp. (“GPMCA”) in their capacity as portfolio managers on behalf of their respective fully managed accounts, beneficially own (directly or indirectly) or exercise control or direction over, in aggregate, the above securities of the Company. R. Abramson indirectly controls both GIACP and GPMCA and is a portfolio manager of both firms. (b) Herbert Abramson, Chairman and a portfolio manager of both GIACP and GPMCA, beneficially owns the securities of the Company. 12 Commitments and contingencies Legal matters From time to time, the Company is party to legal proceedings arising out of the normal course of business. The results of these litigations cannot be predicted with certainty, and management is of the opinion that the outcome of these types of proceedings is generally not determinable. Any loss resulting from these proceedings will be charged to operations in the period the loss is determined. 13 Earnings per share Basic EPS is calculated by dividing the net income (loss) for the period attributable to equity owners of the Company by the weighted average number of common shares outstanding during the period. Diluted EPS is calculated by adjusting the weighted average number of common shares outstanding for dilutive instruments. The number of shares included with respect to options, warrants and similar instruments is computed using the treasury stock method. Three months ended December 31, Six months ended December 31, 2025 2024 2025 2024 Net (loss) and comprehensive (loss) $ (841,799) $ (596,169) $ (1,333,683) $ (943,015) Basic and Diluted EPS Average number of issued common shares during the period 265,390,090 265,390,090 265,390,090 265,390,090 Basic EPS $ (0.00) $ (0.00) $ (0.00) $ (0.00) There are no potentially dilutive common shares outstanding at December 31, 2025 and 2024. 14 14 Nature of expenses Six months ended December 31, 2025 Six months ended December 31, 2024 $ $ Direct expenses Costs of loyalty rewards, and marketing in connection with the Company’s merchant based loyalty program $ 709,614 $ 464,786 Expense for provision against impaired accounts receivable and transaction credits 368,099 37,904 $ 1,077,713 $ 502,690 Selling and Marketing, and General & Administrative Salaries and wages including travel $ 726,499 $ 610,201 Professional fees 249,723 89,315 Facilities, processing, and office expenses 123,018 121,405 Other 21,377 22,329 $ 1,120,617 $ 843,250 15 Segment reporting The Company’s reportable segments include: (1) MCA program, and (2) Aeroplan program. Where applicable, corporate and other activities are reported separately as Corporate. The programs are described in Note 1. The Chief Operating Decision Maker reviews the segment income statement. The segment assets and liabilities are not reviewed. Financial information by reportable segment for period ended December 31, 2025 and December 31, 2024 is tabulated below. Six months ended December 31, 2025 MCA program Aeroplan program Total $ $ $ Revenues 1,441,266 1,091,037 2,532,303 Direct expenses 368,099 709,614 1,077,713 1,073,167 381,423 1,454,590 Selling & marketing 174,642 132,204 306,846 General & administrative 463,160 350,611 813,771 Income (Loss) from operations before depreciation, amortization and interest 435,365 (101,392) 333,973 Interest expense: Loan payable 487,283 - 487,283 9% non-convertible debentures payable 272,143 206,012 478,155 12% non-convertible debe --- ntures payable 23,904 18,096 42,000 CEBA 854 646 1,500 Non-cash interest - 9% non convertible debentures payable 368,701 279,106 647,806 Non-cash interest expense - 12% non-convertible debentures payable 6,211 4,701 10,912 Segment (loss) $ (723,731) $ (609,953) $(1,333,683) 15 Six months ended December 31, 2024 MCA program Aeroplan program Total $ $ $ Revenues 1,139,019 784,123 1,923,142 Direct expenses 37,904 464,786 502,690 1,101,115 319,337 1,420,452 Selling & marketing 141,884 97,675 239,559 General & administrative 357,548 246,143 603,691 Income (Loss) from operations before depreciation, amortization and interest 601,683 (24,481) 577,202 Interest expense: Loan payable 395,673 - 395,673 9% non-convertible debentures payable 283,197 194,958 478,155 12% non-convertible debentures payable 24,875 17,125 42,000 Non-cash interest - 9% non convertible debentures payable 350,610 241,367 591,977 Non-cash interest expense - 12% non-convertible debentures payable 6,463 4,449 10,912 Segment (loss) $ (460,023) $ (482,992) $ (943,015) 16 Government subsidies The Company received $60,000 under the Canada Emergency Business Account in 2022. $20,000 of this loan of $60,000 is forgivable provided the loan is re-paid by January 18, 2024. There is no interest on the $60,000 loan provided it is re-paid by January 18, 2024. After that none of the loan would be forgiven and interest will begin to accrue at 5% per year. The loan was not re-paid by January 18, 2024 and interest of $6,000 has been accrued. Aeroplan is a Registered Trademark of Aeroplan Inc.
View at source ↗